Article Per Year (5 Year)
p-Index From 2019 - 2024
0.92
P-Index
This Author published in this journals
All Journal Jurnal Manajemen Pendidikan JURNAL ILMU KEFARMASIAN INDONESIA Literasi : Jurnal Bahasa dan Sastra Indonesia serta Pembelajarannya Jurnal Ilmiah Wahana Pendidikan Kajian Linguistik dan Sastra Prosiding Seminar Nasional Humaniora Jurnal Manajemen, Bisnis dan Organisasi (JUMBO)
warni warni
Unknown Affiliation
Religion Arts Humanities Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Education Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Social Sciences Other

Published : 7 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : JURNAL ILMU KEFARMASIAN INDONESIA

 1 
Analisis Senyawa Bioaktif Averrhoa bilimbi L. sebagai Penghambat Enzim Siklooksigenasi-2 secara In Siliko Esti Mulatsari; Yati Sumiyati; Warni Warni
JURNAL ILMU KEFARMASIAN INDONESIA Vol 21 No 1 (2023): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v21i1.1284

Abstract

Averrhoa bilimbi L. is generally used as a food flavor enhancer and traditional medicine to treat inflammation, cancer sores, cough, fever, gout, rectal bleeding, and hemorrhoids. In vivo and invitro studies on Averrhoa bilimbi L. have shown anti-inflammatory activity, but the active compounds that play a role in anti-inflammatory activity have not been reported. This study aimed to analyze sixtyfour (64) bioactive compounds in the Averrhoa bilimbi L. plant as cyclooxygenase-2 (COX-2) enzyme inhibitors using in silico approach and predict the pharmacokinetic and toxicological profiles of each compound. The cyclooxygenase-2 enzyme is an enzyme that plays a role in the inflammatory process by converting arachidonic acid into prostaglandin. Increased prostaglandins will cause inflammation. The research method used molecular docking with the application of YASARA, PLANTS, Marvinsketch, Pymol, visualization with PLIP and prediction of ADMET with pkCSM. Control compound used celecoxib. The results showed that there were 13 test compounds that were predicted to have better COX-2 inhibitor activity than celecoxib with good pharmacokinetic properties. Erucic acid has the best pharmacokinetic and toxicity profile. Erucic acid has the potential to be developed as a cyclooxygenase-2 enzyme inhibitor drug.
Co-Authors Aldha Kusuma Wardhani Ayu Diah Lestary Dedy Takdir Syaifuddin Endro Sukotjo Esti Mulatsari Ika Aprianti Irma Suryani Rengki Afria Rustam Rustam Sovia Wulandari Yati Sumiyati